WHO Consultations on Influenza Vaccines
Influenza vaccines are an integral part of a global response to an influenza pandemic. Considerable efforts are ongoing to develop and evaluate candidate pandemic vaccines based on existing and licensed technologies. However, it would be desirable to have processes that can provide pandemic vaccines in large quantities and more quickly than current approaches. WHO will be hosting 3 meetings to be held in Geneva in the next two months to facilitate these processes.
WHO/OIE/FAO consultation on the technical feasibility of human vaccine production in veterinary vaccine production facilities during a pandemic, 27 April 2006.
- Representatives from national regulatory agencies for both human and veterinary influenza vaccines, veterinary influenza vaccine producers.
- To discuss and review issues on the technical feasibility of using veterinary facilities to produce human influenza pandemic vaccines.
- Preliminary assessment of the feasibility of using veterinary vaccine production facilities to reduce the pandemic influenza vaccine supply shortage
- Explore interest from the veterinary vaccine industry and potential vaccine manufacturers
- Inform veterinary vaccine industry on regulatory requirements for human vaccines
- Facilitate exchange of information and activities between veterinary vaccine manufacturers, national regulatory agencies for human medicines and WHO/OIE/FAO
Ministry of Agriculture, China
David Mackay, Riccardo Luigetti
WHO consultation for the development of a global action plan for increasing pandemic vaccine supply, 2-3 May 2006.
- WHO consultation for the development of a global action plan for increasing pandemic vaccine supply, 2-3 May 2006
- Influenza experts, representatives from national immunization programmes and national regulatory authorities, human vaccine manufacturers from both industrialized and developing countries.
- To develop a Global Action Plan outlining short-, mid-, and long-term options to reduce potential pandemic influenza vaccine shortage.
Three working groups will be constituted to develop options on:
- Increasing production capacity - Group 1 ;
- Increasing uptake for seasonal influenza vaccination, focusing on programmatic and policy issues - Group 2;
- Pandemic vaccine research and development - Group 3
These three groups will produce guidance a Global Plan in response to the request of the Fifty-eighth World Health Assembly (WHA 58.5, Agenda item 13.9 23 May 2005) in which WHO is to seek solutions with international and national partners, including the private sector, to reduce the present global vaccine shortage of influenza vaccines, both seasonal and pandemic, including approaches for research and development of novel vaccines.
WHO meeting on clinical trials of influenza pandemic vaccines, 4-5 May 2006
- Representatives from the vaccine industry, researchers from universities/academic institutions with ongoing pandemic vaccine clinical trials
- A follow-up meeting to the WHO meeting held in November 2005 on the development and evaluation of clinical trials for pandemic vaccines.